EIB plans large loan for Belgian pharma firm
The European Investment Bank (EIB) is planning to lend Euro 400m to a 'leading international' Belgium-based pharmaceutical company that also makes plastics and chemicals.
The European Investment Bank (EIB) is planning to lend Euro 400m to a 'leading international' Belgium-based pharmaceutical company that also makes plastics and chemicals.
The bank said the money would help fund the company's current €1bn three-year spending plan covering its 'r&d related activities and investments in the pharmaceuticals sector'.